PBM
Search results
Scope
Date
~
-
Bio & PharmaCelltrion's Zymfentra gets 90% distribution channel in US
South Korean biosimilar maker Celltrion Inc. said on Monday its subcutaneous injection formulation for autoimmune diseases, Zymfentra (infliximab), ...
Oct 30, 2024 (Gmt+09:00)
-
Bio & PharmaCelltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
1
Latest News
- 1 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 2 Korea to allow non-profits to buy consumer bad loans
- 3 LG to drive future growth in emerging markets with battery prowess
- 4 South Korean President Lee, Japanese Prime Minister Ishiba seek closer ties
- 5 Naver Ventures to plant flag in Silicon Valley with TwelveLabs bet
